Sobre Mi:
Mr. Jorge Maisonet is a molecular biologist and the founder of The Mizonett Group, an organization that supports innovations in the healthcare industry. He believes in contributing to the evolution of the health industry through the discovery, development and commercialization of novel health alternatives. His vision is to expand the access to health services through his organization by generating actual health solutions that include low-income and marginalized populations, ranging from health education and prevention to health financing, healthcare delivery and pharmaceutical development.
Currently, the most important business project of The Mizonett Group is the development of iSelectMD Corporation, an online-based company that aims to cross-connect healthcare systems and expand the access to health services. Mr. Maisonet is responsible for the vision of the business and services of iSelectMD.
During his doctoral studies in Cancer Biology at The University of Texas M.D. Anderson Cancer Center, Mr. Maisonet, worked on the development of novel anti-cancer drugs. Concurrently, he joined one of the most active science-oriented entrepreneurial societies in the United States through organizations such as BioHouston, The Rice Alliance for Technology and Entrepreneurship and The Houston Technology Center. That environment allowed Mr. Maisonet to develop a strong interest and understanding of the economics applied to the development and commercialization of health advances. The field of biomedical and health economics has become the focus of his career, with a particular interest in how the use of creative capitalism can benefit noble causes such as the fight against cancer, global health and poverty.
Prior to his doctoral studies, Mr. Maisonet, completed a Bachelor of Science from The University of Puerto Rico, and five years of experience in molecular research from several institutions such as Weill Medical School of Cornell University, The Puerto Rico Cancer Center, The University of Puerto Rico and The University of Texas M.D. Anderson Cancer Center.
Información de proyecto:
The development of iSelectMD Corporation. iSelectMD is an online scheduling management company specialized in the healthcare industry. The company envisions a future where patients are able to schedule and manage medical services online. It created a novel system that empowers patients with online medical scheduling services and simultaneously provides tools to connect healthcare systems. These services target an untapped multi-billion dollar market.